Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | -17.80% | +4.62% | +163.38% |
Financials (USD)
Sales 2024 * | 2.6M | Sales 2025 * | 30.14M | Capitalization | 891M |
---|---|---|---|---|---|
Net income 2024 * | -113M | Net income 2025 * | -97M | EV / Sales 2024 * | 343 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 29.6 x |
P/E ratio 2024 * |
-7.65
x | P/E ratio 2025 * |
-9.47
x | Employees | 184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.52% |
Latest transcript on Humacyte, Inc.
1 day | -17.80% | ||
1 week | +4.62% | ||
1 month | +90.82% | ||
3 months | +71.95% | ||
6 months | +182.26% | ||
Current year | +163.38% |
Managers | Title | Age | Since |
---|---|---|---|
Laura Niklason
FOU | Founder | 61 | 04-10-12 |
Dale Sander
DFI | Director of Finance/CFO | 64 | 21-08-25 |
Shamik Parikh
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Binder
BRD | Director/Board Member | 88 | 21-08-25 |
Brady Dougan
BRD | Director/Board Member | 64 | 21-08-25 |
Laura Niklason
FOU | Founder | 61 | 04-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.48 | -17.80% | 8,814,356 |
24-05-30 | 9.1 | +18.03% | 8,180,050 |
24-05-29 | 7.71 | +2.94% | 1,926,589 |
24-05-28 | 7.49 | +4.76% | 1,494,523 |
24-05-24 | 7.15 | -0.83% | 1,454,939 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.38% | 891M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- HUMA Stock